Background illustration for clinical trials search

Paid Clinical Trials Nashville

Discover 1,239 paid clinical trials in Nashville, Tennessee. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Study of JNJ-95437446 in Participants With Advanced-Stage Solid Tumors

for
Advanced Stage Solid Tumors
Location: Nashville TN, Fairfax VA, Sarasota FL, New York NY
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT07107230

Phase 1, Recruiting

A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)

for
Non-small Cell Carcinoma, Non-Small Cell Lung Cancer Metastatic,
Location: Nashville TN, Smyrna TN, Mount Juliet TN, Lebanon TN,
Sponsor: Pfizer

Sex: All

Age: 18+

Code: NCT07144280

Phase 3, Recruiting

A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Lower Risk Myelodysplastic Syndromes (LR-MDS) Who Need Regular Blood Transfusions

for
Myelodysplastic Syndrome, Anemia
Location: Nashville TN, Louisville KY, Atlanta GA, Skokie IL,
Sponsor: Takeda

Sex: All

Age: 18+

Code: NCT07422480

Phase 3, Recruiting

Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer

for
Carcinoma, Renal Cell, Advanced Renal Cell Carcinoma,
Location: Nashville TN, Hendersonville TN, Franklin TN, Smyrna TN,
Sponsor: Pfizer

Sex: All

Age: 18+

Code: NCT07227415

Phase 1, Phase 2, Recruiting

A Study to Assess BMS-986453 in Participants With Relapsed and/or Refractory Multiple Myeloma

for
Relapsed and/or Refractory Multiple Myeloma
Location: Nashville TN, Birmingham AL, Tampa FL, New York NY,
Sponsor: Juno Therapeutics, Inc., a Bristol-Myers Squibb Company

Sex: All

Age: 18+

Code: NCT06153251

Phase 1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Phase 1 Study of OP-3136 in Advanced or Metastatic Solid Tumors

for
Advanced or Metastatic ER+ HER2- Breast Cancer (mBC),
Location: Nashville TN, Columbus OH, Grand Rapids MI, Sarasota FL,
Sponsor: Olema Pharmaceuticals, Inc.

Sex: All

Age: 18+

Code: NCT06784193

Phase 1, Recruiting

Trial of Therapeutic Cancer Vaccine OSE2101 in Patients With Non-Small Cell Lung Cancer and Secondary Resistance to Immune Checkpoint Inhibitor

for
Patients With Non-Small Cell Lung Cancer
Location: Nashville TN, Franklin TN, Smyrna TN, Shelbyville TN,
Sponsor: OSE Immunotherapeutics

Sex: All

Age: 18+

Code: NCT06472245

Phase 3, Recruiting

Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer

for
Carcinoma, Non-Small-Cell Lung
Location: Nashville TN, Huntsville AL, Chattanooga TN,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT06890598

Phase 3, Recruiting

ATEMPT 2.0: Adjuvant T-DM1 vs TH

for
Breast Cancer, HER2-positive Breast Cancer
Location: Nashville TN, Columbus OH, Chicago IL, Pittsburgh PA,
Sponsor: Dana-Farber Cancer Institute

Sex: All

Age: 18+

Code: NCT04893109

Phase 2, Recruiting

A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast Cancer

for
Locally Advanced Breast Cancer, Unresectable Breast Carcinoma,
Location: Nashville TN, Atlanta GA, Athens GA, St Louis MO,
Sponsor: BioNTech SE

Sex: All

Age: 18+

Code: NCT06827236

Phase 1, Phase 2, Recruiting

Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Participants With Metastatic Colorectal Cancer With KRAS p.G12C Mutation

for
Metastatic Colorectal Cancer
Location: Nashville TN, Pikeville KY, Chicago IL, Durham NC,
Sponsor: Amgen

Sex: All

Age: 18+

Code: NCT06252649

Phase 3, Recruiting

Pan Tumor Rollover Study

for
Cancer
Location: Nashville TN, Louisville KY, Cincinnati OH, Columbus OH,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18+

Code: NCT03899155

Phase 2, Recruiting

Clinical Trial of N-803 Plus Tislelizumab or Prior Failed Immune Checkpoint Inhibitor and Docetaxel Versus Docetaxel Monotherapy in Participants With Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Acquired Resistance to Immune Checkpoint In

for
NSCLC Stage IV
Location: Nashville TN, Atlanta GA, Cincinnati OH, St Louis MO,
Sponsor: ImmunityBio, Inc.

Sex: All

Age: 18 - 70+

Code: NCT06745908

Phase 3, Recruiting

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

for
Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis
Location: Nashville TN, Huntsville AL, Chattanooga TN,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT06119581

Phase 3, Recruiting

A Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid Tumors

for
HER2-positive Advanced Solid Tumor
Location: Nashville TN, Newnan GA, Saint Louis MO, Chicago IL,
Sponsor: DualityBio Inc.

Sex: All

Age: 18+

Code: NCT05150691

Phase 1, Phase 2, Recruiting

A Study of Sacituzumab Govitecan Given at an Alternative Dose and Schedule in Participants With Advanced Triple-Negative Breast Cancer

for
Triple Negative Breast Cancer
Location: Nashville TN, Germantown TN, Atlanta GA, St Louis MO,
Sponsor: Gilead Sciences

Sex: All

Age: 18+

Code: NCT06926920

Phase 1, Phase 2, Recruiting

Study to Assess the Efficacy and Safety of Rina-S in Participants With Non-small Cell Lung Cancer

for
Non-small Cell Lung Cancer (NSCLC)
Location: Nashville TN, Atlanta GA, Chapel Hill NC, Fairfax VA,
Sponsor: Genmab

Sex: All

Age: 18+

Code: NCT07288177

Phase 2, Recruiting

Pacritinib Effectiveness in Real-world Settings

for
Myelofibrosis (MF)
Location: Nashville TN, Columbus OH, Charleston SC, Tampa FL,
Sponsor: Swedish Orphan Biovitrum

Sex: All

Age: 18+

Code: NCT07774455

Recruiting

First in Human Study of BAY2927088 in Participants Who Have Advanced Non-small Cell Lung Cancer (NSCLC) With Mutations in the Genes of Epidermal Growth Factor Receptor (EGFR) and/or Human Epidermal Growth Factor Receptor 2 (HER2)

for
Advanced Non-small Cell Lung Cancer, EGFR Mutation,
Location: Nashville TN
Sponsor: Bayer

Sex: All

Age: 18+

Code: NCT05099172

Phase 1, Phase 2, Recruiting

A Master Protocol to Evaluate the Long-Term Safety of (LY3527727) Pirtobrutinib

for
Chronic Lymphocytic Leukemia, Non-Hodgkin Lymphoma
Location: Nashville TN, Columbus OH, Durham NC, Milwaukee WI,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT06876649

Recruiting